SRC and colorectal carcinoma: Expression of this SRC mutant increased SRC activity (as measured by P-SRC Y419) and promoted migration and invasion [36], similar to a native, human truncating mutation in the negative regulatory domain of SRC (SRC 531) we previously identified in CRC [20].